entertainment -WSS

entertainment

author：leisure time 2025-09-03 09:22:38 - browse：87886

Medicare generally pays far more for CAR-T drugs that are administered in outpatient departments than it does for inpatient care. Adobe

WASHINGTON — Hospitals for years have complained that Medicare pays so little for CAR-T cancer treatments that they sometimes lose money administering the incredibly expensive treatments. But that could soon change: if drug companies succeed in making the cancer treatments safer, hospitals could provide them more often in outpatient departments, where payment is higher.

CAR-T uses the body’s own immune system to kill cancerous cells. The procedure, regulated as a drug, involves taking T cells from a patient’s blood, adding chimeric antigen receptors (CAR) to the T cells that kill cancer, and injecting the CAR-T treatment back into the patient.

It’s worked wonders in many cancer patients who have run out of options. But right now it’s almost exclusively administered in hospitals, because the side effects can require aggressive treatments. In many cases, the CAR-T cells trigger immune reactions that can be life-threatening.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： AbbVie dramatically boosts its spending on lobbying

leisure time

WSS

First over

Medicare drug price negotiation continues, as pharma counteroffers

How artificial intelligence is being used to detect, treat cancer

The public health thinking behind the CDC’s new Covid guidance

White House launches permanent pandemic office

State of the Union pitch: Bigger Medicare drug price negotiations

Wikipedia

entertainment

focus

Drug repurposing or repositioning? The language matters

Body of missing toddler recovered in Delaware River days after flood: Police

Peter Hotez and the public health issue of online harassment

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

Guidelines to prevent youth baseball injuries need more muscle

In new study, freeze

BioMarin wins approval for gene therapy to treat hemophilia A

Artificial intelligence advances fuel industry trying to preserve loved ones after death

Medicare details structure of new drug price negotiation program

As Taiwan prepares for anti

hotspot

In new study, freeze

Fetal cell organoids grown from amniotic fluid, study finds

Change Healthcare: What is it, why does its cyberattack matter?

Change Healthcare: What is it, why does its cyberattack matter?

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Caitlin Bernard's story shows physicians can't shy from advocacy

leisure time

focus

leisure time

hotspot